{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:18Z","timestamp":1707524298152},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,6]]},"DOI":"10.7759\/cureus.16207","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T11:54:44Z","timestamp":1625572484000},"source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C Viral Infection Among Beta-Thalassemia Patients: A Study From the Centre for Excellence in Thalassemia and Other Blood Disorders"],"prefix":"10.7759","author":[{"given":"Venkataramana","family":"Kandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sravani Reddy","family":"Vinjamuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhanu Pravallika","family":"Tanikella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0703.1000e117","article-title":"Viral hepatitis: an insight in to chronic liver disease caused by hepatitis C virus (HCV)","volume":"2","author":"Ramana KV","year":"2013","unstructured":"Ramana KV. Viral hepatitis: an insight in to chronic liver disease caused by hepatitis C virus (HCV). J Med Microb Diagn. 2013, 2:e117. 10.4172\/2161-0703.1000e117","journal-title":"J Med Microb Diagn"},{"key":"ref2","unstructured":"Hepatitis C. (2021). Accessed. June 20, 2021: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4178\/epih\/e2015008","article-title":"Effect of co-morbidities on disease course in human immunodeficiency virus-infected illicit drug users in the era of highly active antiretroviral therapy","volume":"37","author":"Kandi V","year":"2015","unstructured":"Kandi V. Effect of co-morbidities on disease course in human immunodeficiency virus-infected illicit drug users in the era of highly active antiretroviral therapy. Epidemiol Health. 2015, 37:e2015008. 10.4178\/epih\/e2015008","journal-title":"Epidemiol Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100588","article-title":"Challenges of blood transfusions in \u03b2-thalassemia","volume":"37","author":"Shah FT","year":"2019","unstructured":"Shah FT, Sayani F, Trompeter S, Drasar E, Piga A. Challenges of blood transfusions in \u03b2-thalassemia. Blood Rev. 2019, 37:100588. 10.1016\/j.blre.2019.100588","journal-title":"Blood Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2019.01.003","article-title":"Beta thalassemia: monitoring and new treatment approaches","volume":"33","author":"Khandros E","year":"2019","unstructured":"Khandros E, Kwiatkowski JL. Beta thalassemia: monitoring and new treatment approaches. Hematol Oncol Clin North Am. 2019, 33:339-53. 10.1016\/j.hoc.2019.01.003","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.08.060","article-title":"Approaches, progress, and challenges to hepatitis C vaccine development","volume":"156","author":"Bailey JR","year":"2019","unstructured":"Bailey JR, Barnes E, Cox AL. Approaches, progress, and challenges to hepatitis C vaccine development. Gastroenterology. 2019, 156:418-30. 10.1053\/j.gastro.2018.08.060","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2019.08.004","article-title":"Viral hepatitis: etiology, epidemiology, transmission, diagnostics, treatment, and prevention","volume":"33","author":"Lanini S","year":"2019","unstructured":"Lanini S, Ustianowski A, Pisapia R, Zumla A, Ippolito G. Viral hepatitis: etiology, epidemiology, transmission, diagnostics, treatment, and prevention. Infect Dis Clin North Am. 2019, 33:1045-62. 10.1016\/j.idc.2019.08.004","journal-title":"Infect Dis Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093057","article-title":"Hepatitis C virus and hepatocellular carcinoma: when the host loses its grip","volume":"21","author":"Goto K","year":"2020","unstructured":"Goto K, Roca Suarez AA, Wrensch F, Baumert TF, Lupberger J. Hepatitis C virus and hepatocellular carcinoma: when the host loses its grip. Int J Mol Sci. 2020, 21:3057. 10.3390\/ijms21093057","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002299","article-title":"Intrafamilial transmission of hepatitis C virus among families of infected pediatric oncology patients","volume":"38","author":"Sherief LM","year":"2019","unstructured":"Sherief LM, Beshir MR, Salem GM, et al.. Intrafamilial transmission of hepatitis C virus among families of infected pediatric oncology patients. Pediatr Infect Dis J. 2019, 38:692-7. 10.1097\/INF.0000000000002299","journal-title":"Pediatr Infect Dis J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i19.5897","article-title":"Determining hepatitis C virus genotype distribution among high-risk groups in Iran using real-time PCR","volume":"20","author":"Jamalidoust M","year":"2014","unstructured":"Jamalidoust M, Namayandeh M, Asaei S, Aliabadi N, Ziyaeyan M. Determining hepatitis C virus genotype distribution among high-risk groups in Iran using real-time PCR. World J Gastroenterol. 2014, 20:5897-902. 10.3748\/wjg.v20.i19.5897","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_879_20","article-title":"A demographic prevalence of \u03b2 Thalassemia carrier and other hemoglobinopathies in adolescent of Tharu population","volume":"9","author":"Nigam N","year":"2020","unstructured":"Nigam N, Kushwaha R, Yadav G, et al.. A demographic prevalence of \u03b2 Thalassemia carrier and other hemoglobinopathies in adolescent of Tharu population. J Family Med Prim Care. 2020, 9:4305-10. 10.4103\/jfmpc.jfmpc_879_20","journal-title":"J Family Med Prim Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.00007","article-title":"HCV infection in thalassemia syndromes and hemoglobinopathies: new perspectives","volume":"7","author":"Maffei L","year":"2020","unstructured":"Maffei L, Sorrentino F, Caprari P, Taliani G, Massimi S, Risoluti R, Materazzi S. HCV infection in thalassemia syndromes and hemoglobinopathies: new perspectives. Front Mol Biosci. 2020, 7:7. 10.3389\/fmolb.2020.00007","journal-title":"Front Mol Biosci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00485-5","article-title":"Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis","volume":"16","author":"Platt L","year":"2016","unstructured":"Platt L, Easterbrook P, Gower E, et al.. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis. 2016, 16:797-808. 10.1016\/S1473-3099(15)00485-5","journal-title":"Lancet Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30303-4","article-title":"Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis","volume":"6","author":"Jin F","year":"2021","unstructured":"Jin F, Dore GJ, Matthews G, et al.. Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021, 6:39-56. 10.1016\/S2468-1253(20)30303-4","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14466","article-title":"Burden of hepatitis C virus infection in India: q systematic review and meta-analysis","volume":"34","author":"Goel A","year":"2019","unstructured":"Goel A, Seguy N, Aggarwal R. Burden of hepatitis C virus infection in India: q systematic review and meta-analysis. J Gastroenterol Hepatol. 2019, 34:321-9. 10.1111\/jgh.14466","journal-title":"J Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016","volume":"69","author":"Hofmeister MG","year":"2019","unstructured":"Hofmeister MG, Rosenthal EM, Barker LK, et al.. Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016. Hepatology. 2019, 69:1020-31. 10.1002\/hep.30297","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-020-09591-6","article-title":"HCV and HEV: two players in an Egyptian village, a study of prevalence, incidence, and co-infection","volume":"27","author":"Elhendawy M","year":"2020","unstructured":"Elhendawy M, Abo-Ali L, Abd-Elsalam S, et al.. HCV and HEV: two players in an Egyptian village, a study of prevalence, incidence, and co-infection. Environ Sci Pollut Res Int. 2020, 27:33659-67. 10.1007\/s11356-020-09591-6","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64309-5","article-title":"Diverse HCV strains and HIV URFS identified amongst people who inject drugs in India","volume":"10","author":"Rodgers MA","year":"2020","unstructured":"Rodgers MA, Gomathi S, Vallari A, et al.. Diverse HCV strains and HIV URFS identified amongst people who inject drugs in India. Sci Rep. 2020, 10:7214. 10.1038\/s41598-020-64309-5","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2014.05.006","article-title":"Consensus statement of HCV task force of the Indian National Association for Study of the Liver (INASL). Part I: status report of HCV infection in India","volume":"4","author":"Puri P","year":"2014","unstructured":"Puri P, Anand AC, Saraswat VA, et al.. Consensus statement of HCV task force of the Indian National Association for Study of the Liver (INASL). Part I: status report of HCV infection in India. J Clin Exp Hepatol. 2014, 4:106-16. 10.1016\/j.jceh.2014.05.006","journal-title":"J Clin Exp Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2016.09.005","article-title":"Tackling the hepatitis C disease burden in Punjab, India","volume":"6","author":"Dhiman RK","year":"2016","unstructured":"Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the hepatitis C disease burden in Punjab, India. J Clin Exp Hepatol. 2016, 6:224-32. 10.1016\/j.jceh.2016.09.005","journal-title":"J Clin Exp Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1089\/heq.2019.0005","article-title":"High prevalence of hepatitis C virus infection in primitive tribes of Eastern India and associated sociobehavioral risks for transmission: a retrospective analysis","volume":"3","author":"Kar SK","year":"2019","unstructured":"Kar SK, Sabat J, Ho LM, Arora R, Dwibedi B. High prevalence of hepatitis C virus infection in primitive tribes of Eastern India and associated sociobehavioral risks for transmission: a retrospective analysis. Health Equity. 2019, 3:567-72. 10.1089\/heq.2019.0005","journal-title":"Health Equity"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001926","article-title":"Seroprevalence of anti-HIV-1, anti-HIV-2, hepatitis B surface antigen, and anti-HCV in eye donors in a tertiary eye hospital, Chennai, India, in the past 13 years (2005-2017)","volume":"38","author":"Kulandhai LT","year":"2019","unstructured":"Kulandhai LT, Bhagavathi H, Krishnan S, Krishnan K, Balasubramaniyam M, Madhavan HN. Seroprevalence of anti-HIV-1, anti-HIV-2, hepatitis B surface antigen, and anti-HCV in eye donors in a tertiary eye hospital, Chennai, India, in the past 13 years (2005-2017). Cornea. 2019, 38:737-41. 10.1097\/ICO.0000000000001926","journal-title":"Cornea"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/ijmm.IJMM_19_17","article-title":"The prevalence of anti-hepatitis C antibody among acute febrile illness cases in Idar Taluk, Gujarat, West India","volume":"37","author":"Nikitha S","year":"2019","unstructured":"Nikitha S, Sabeena S, Robin S, et al.. The prevalence of anti-hepatitis C antibody among acute febrile illness cases in Idar Taluk, Gujarat, West India. Indian J Med Microbiol. 2019, 37:225-9. 10.4103\/ijmm.IJMM_19_17","journal-title":"Indian J Med Microbiol"},{"key":"ref24","article-title":"Seroprevalence and co-infection of hepatitis B and hepatitis C among patients in a tertiary care hospital in Eastern India","volume":"67","author":"Rahaman J","year":"2019","unstructured":"Rahaman J, Sengupta M, Barik G, Sarkar S, Sarkar R, Sengupta M. Seroprevalence and co-infection of hepatitis B and hepatitis C among patients in a tertiary care hospital in Eastern India. J Assoc Physicians India. 2019, 67:27-29.","journal-title":"J Assoc Physicians India"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.18502\/ijm.v12i6.5041","article-title":"Prevalence of hepatitis C among haemodialysis patients in a tertiary care hospital in south India","volume":"12","author":"Madhavan A","year":"2020","unstructured":"Madhavan A, Sachu A, Balakrishnan AK, Vasudevan A, Balakrishnan S, Vasudevapanicker J. Prevalence of hepatitis C among haemodialysis patients in a tertiary care hospital in south India. Iran J Microbiol. 2020, 12:644-9. 10.18502\/ijm.v12i6.5041","journal-title":"Iran J Microbiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2018.08.001","article-title":"Prevalence and genotyping pattern of hepatitis C\u00a0virus among patients on maintenance hemodialysis at five centers in Pune, India","volume":"75","author":"Roy P","year":"2019","unstructured":"Roy P, Patel A, Lole K, Gupta RM, Kumar A, Hazra S. Prevalence and genotyping pattern of hepatitis C\u00a0virus among patients on maintenance hemodialysis at five centers in Pune, India. Med J Armed Forces India. 2019, 75:74-80. 10.1016\/j.mjafi.2018.08.001","journal-title":"Med J Armed Forces India"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_449_19","article-title":"Menace of Hepatitis C virus among multitransfused thalassemia patients in Balasore district of Odisha state in India","volume":"8","author":"Sinha MK","year":"2019","unstructured":"Sinha MK, Raghuwanshi B, Mishra B. Menace of Hepatitis C virus among multitransfused thalassemia patients in Balasore district of Odisha state in India. J Family Med Prim Care. 2019, 8:2850-4. 10.4103\/jfmpc.jfmpc_449_19","journal-title":"J Family Med Prim Care"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2020.038","article-title":"A seroprevalence of HBV, HCV and HIV-1 and correlation with molecular markers among multi-transfused thalassemia patients in Western India","volume":"12","author":"Mishra K","year":"2020","unstructured":"Mishra K, Shah A, Patel K, Ghosh K, Bharadva S. A seroprevalence of HBV, HCV and HIV-1 and correlation with molecular markers among multi-transfused thalassemia patients in Western India. Mediterr J Hematol Infect Dis. 2020, 12:e2020038. 10.4084\/MJHID.2020.038","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2020.006","article-title":"A concise review on the frequency, major risk factors and surveillance of hepatocellular carcinoma (HCC) in \u03b2-thalassemias: past, present and future perspectives and the ICET-A experience","volume":"12","author":"De Sanctis V","year":"2020","unstructured":"De Sanctis V, Soliman AT, Daar S, et al.. A concise review on the frequency, major risk factors and surveillance of hepatocellular carcinoma (HCC) in \u03b2-thalassemias: past, present and future perspectives and the ICET-A experience. Mediterr J Hematol Infect Dis. 2020, 12:e2020006. 10.4084\/MJHID.2020.006","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref30","article-title":"Prevalence of hepatitis C among multi-transfused thalassaemic patients in Oman: single centre experience","volume":"15","author":"Al-Naamani K","year":"2015","unstructured":"Al-Naamani K, Al-Zakwani I, Al-Sinani S, Wasim F, Daar S. Prevalence of hepatitis C among multi-transfused thalassaemic patients in Oman: single centre experience. Sultan Qaboos Univ Med J. 2015, 15:46-51.","journal-title":"Sultan Qaboos Univ Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/63261-hepatitis-c-viral-infection-among-beta-thalassemia-patients-a-study-from-the-centre-for-excellence-in-thalassemia-and-other-blood-disorders","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:32Z","timestamp":1707506792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/63261-hepatitis-c-viral-infection-among-beta-thalassemia-patients-a-study-from-the-centre-for-excellence-in-thalassemia-and-other-blood-disorders"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.16207","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,6]]}}}